Literature DB >> 27265449

Pneumococcal carriage in young children after introduction of PCV13 in Hong Kong.

Kate Ching Ching Chan1, Reema Subramanian2, Patrick Chong3, E Anthony S Nelson1, Hugh Simon Lam1, Albert Martin Li1, Margaret Ip4.   

Abstract

OBJECTIVES: Pneumococcal conjugate vaccine (PCV) has been included in Hong Kong's Childhood Immunization Programme since 2009. This study aimed to assess nasopharyngeal pneumococcal carriage rate, serotypes and antimicrobial resistance pattern in young children after the introduction of 13-valent PCV (PCV13). STUDY
DESIGN: A community-based, cross-sectional surveillance study was performed on healthy infants attending eleven Maternal and Child Health Centres across different parts of Hong Kong. Nasopharyngeal swabs were obtained from healthy children aged 2, 12 and 18months during their visit to the centers for immunization from June 2013 to June 2014. Pneumococcal isolates were serotyped and tested for antimicrobial resistance. Details of the demographics, family composition, vaccination history and medical history was obtained through interview of the guardians.
RESULTS: 1541 children were recruited. The overall carriage rate was 5.5%. Children aged 12 and 18months were more likely to have pneumococcal colonization (12months OR: 2.88; 95% CI: 1.41-5.87 and 18months OR: 2.19, 95% CI: 1.05-4.57). Recent respiratory symptoms and presence of siblings younger than 6years were independently associated with pneumococcal carriage. Eighty-four pneumococcal isolates were serotyped. The most prevalent serogroup/types were 15 (15B/C, 16.7%; 15A/F, 9.5%), 6C (15.5%) and 23A (13.1%). Overall, 2.4% of the isolates were heptavalent PCV serotypes, 10.7% were PCV13 serotypes and 89.3% were non-PCV13 serotypes. The proportions of penicillin, cefotaxime and erythromycin non-susceptible isolates were 7.3%, 13.4% and 79.3% respectively.
CONCLUSION: The rate of pneumococcal carriage was low in young children in Hong Kong and compared to previous local studies there appears to have been an overall reduction in the carriage rate after the introduction of PCV. Likely serotype replacement was noted with a predominance of non-vaccine serotypes in pneumococcal carriage with the emergence of serogroup/type 15 and 6C.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Nasopharyngeal carriage; Pneumococcal conjugate vaccine; Streptococcus pneumoniae

Mesh:

Substances:

Year:  2016        PMID: 27265449     DOI: 10.1016/j.vaccine.2016.05.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China.

Authors:  Yan Xu; Qing Wang; Kaihu Yao; Fang Dong; Wenqi Song; Gang Liu; Baoping Xu; Wei Shi; Yue Li; Kechun Li; Yingchao Liu; Suyun Qian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-31       Impact factor: 3.267

2.  Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey.

Authors:  Ayşe Büyükcam; Hüseyin Güdücüoğlu; Kamuran Karaman; Venhar Gürbüz; Emil Aliyev; Ateş Kara; Mehmet Ceyhan
Journal:  Hum Vaccin Immunother       Date:  2017-06-02       Impact factor: 3.452

3.  Population-based estimates of the burden of pneumonia hospitalizations in Hong Kong, 2011-2015.

Authors:  Xue Li; Joseph E Blais; Ian C K Wong; Anthony W Y Tam; Benjamin J Cowling; Ivan F N Hung; Esther W Y Chan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-25       Impact factor: 3.267

4.  Serotype prevalence and antibiotic susceptibility patterns of pneumococcal isolates in Zunyi city, China.

Authors:  Meijing Shen; Run Yao; Huan Yue; Jingzhi Zhang; Min Chen; Weiwei Zhang; Daishun Liu; Kaifeng Wu
Journal:  Saudi Med J       Date:  2017-12       Impact factor: 1.484

5.  Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case-control study.

Authors:  Moana Mika; Josua Maurer; Insa Korten; Aurélie Allemann; Suzanne Aebi; Silvio D Brugger; Weihong Qi; Urs Frey; Philipp Latzin; Markus Hilty
Journal:  Microbiome       Date:  2017-07-24       Impact factor: 14.650

6.  Pneumococcal carriage and serotype distribution among children with and without pneumonia in Mozambique, 2014-2016.

Authors:  Tolulope Adebanjo; Fernanda C Lessa; Helio Mucavele; Benild Moiane; Alberto Chauque; Fabiana Pimenta; Sergio Massora; Maria da Gloria Carvalho; Cynthia G Whitney; Betuel Sigauque
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

7.  Household environmental tobacco smoke exposure in healthy young children in Hong Kong: Prevalence and risk factors.

Authors:  Siyu Dai; Kate Ching Ching Chan
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

8.  Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong.

Authors:  Salini Mohanty; Tianyan Hu; GyongSeon Yang; Tsz K Khan; Kwame Owusu-Edusei; Isaya Sukarom
Journal:  Hum Vaccin Immunother       Date:  2022-04-14       Impact factor: 4.526

9.  Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys.

Authors:  Eleanor F G Neal; Cattram D Nguyen; Felista T Ratu; Eileen M Dunne; Mike Kama; Belinda D Ortika; Laura K Boelsen; Joseph Kado; Lisi Tikoduadua; Rachel Devi; Evelyn Tuivaga; Rita C Reyburn; Catherine Satzke; Eric Rafai; E Kim Mulholland; Fiona M Russell
Journal:  PLoS One       Date:  2020-04-01       Impact factor: 3.240

10.  Associations of household environmental tobacco smoke exposure with respiratory symptoms and utilisation of medical services in healthy young children in Hong Kong.

Authors:  Siyu Dai; Kate C Chan
Journal:  Tob Induc Dis       Date:  2020-01-10       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.